SCHEMBL22157686

SCHEMBL22157686

Fc1cc(F)cc(-c2c(-n3c4ccccc4c4ccc5c6ccccc6oc5c43)cc(C(F)(F)F)cc2-n2c3ccccc3c3ccc4c5ccccc5oc4c32)c1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KIF11 P52732 1/20 0.34
▸ CYP1A1 P04798 1/20 0.33
▸ CYP1A2 P05177 1/20 0.33
▸ CYP2E1 P05181 1/20 0.33
▸ CYP3A4 P08684 1/20 0.33
▸ CYP2C8 P10632 1/20 0.33
▸ CYP2D6 P10635 1/20 0.33
▸ CYP2A6 P11509 1/20 0.33
▸ CYP2C9 P11712 1/20 0.33
▸ CYP4B1 P13584 1/20 0.33
▸ CYP2B6 P20813 1/20 0.33
▸ CYP3A5 P20815 1/20 0.33
▸ CYP2A7 P20853 1/20 0.33
▸ CYP3A7 P24462 1/20 0.33
▸ CYP2F1 P24903 1/20 0.33
▸ CYP2C18 P33260 1/20 0.33
▸ CYP2C19 P33261 1/20 0.33
▸ CYP2J2 P51589 1/20 0.33
▸ CYP4F2 P78329 1/20 0.33
▸ CYP4F8 P98187 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22157690 0.87 KIF11 (0.34) KIF11CYP1A1CYP1A2CYP2E1CYP3A4
SCHEMBL22156032 0.87 KIF11 (0.35) KIF11CYP1A1CYP1A2CYP2E1CYP3A4
SCHEMBL22157740 0.86 KIF11 (0.34) KIF11CYP1A1CYP1A2CYP2E1CYP3A4
SCHEMBL22157760 0.86 ALDH1A1 (0.31) KIF11CYP1A1CYP1A2CYP2E1CYP3A4
SCHEMBL22156873 0.84 GRM5 (0.34) —
SCHEMBL22564557 0.84 RXRA (0.33) KIF11CYP1A1CYP1A2CYP2E1CYP3A4
SCHEMBL22760773 0.82 MAT2A (0.35) KIF11CYP1A1CYP1A2CYP2E1CYP3A4
SCHEMBL22157714 0.82 ALOX5 (0.31) CDC14BCDC14A
SCHEMBL22157264 0.81 ALOX5 (0.31) CDC14BCDC14A
SCHEMBL22156048 0.81 KDM4E (0.40) KIF11TACR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3635070-B1 ORGANIC MOLECULES, IN PARTICULAR FOR USE IN OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2021-04-28 — — EP disclosed
US-20200203628-A1 ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2020-06-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200203628-A1 ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES OR10J3, ORC3, OR51E2 KIF11 4485/4885CYP1A1 1585/4885CYP1A2 1082/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback